Proposed Skinvisible (SKVI), Quoin Pharmaceuticals Merger to Address Opioid Pain Management Market
A merger between Skinvisible and Quoin Pharmaceuticals will enable a successful entry on the post-surgical pain management market Aging populations and a large number of surgical interventions in the West have contributed to significant market expansion By 2024, the pain management therapeutics market is expected to reach $83 billion Skinvisible Pharmaceuticals (OTCQB: SKVI) recently announced that it has signed a Letter of Intent for a proposed merger with Quoin Pharmaceuticals Limited – a partnership that could address significant unmet medical needs on the pain management market. If both parties agree on the terms, the merger should be completed next year,…